Delivery Order SPE2DB22D2005-SPE2DB25FJQB4
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Benlysta 200 mg/ml syringes valued at $12,305.60 with an ultimate completion date of October 7, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $6,152.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Benlysta 200 mg/ml syringes. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 1, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $12,305.60 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes, with an ultimate completion date of October 1, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/mL syringes valued at $6,152.80, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BENLYSTA 200 mg/mL auto-injector medication. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of August 18, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,076.40 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL syringes, with a completion date of May 15, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside structure, to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200MG VL 1S pharmaceutical product on September 13, 2025. This firm fixed price delivery order, valued at $3,082.67, represents a competitive award with no set-aside designation and is scheduled for completion by September 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $6,152.80 delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml syringes. The award, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $6,165.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 MG/ML auto-injector pharmaceutical supplies. The contract, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, represents a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQB4Delivery Order
The Defense Logistics Agency awarded a $3,076.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml syringes, with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Defense Health Agency and military healthcare systems. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains through its extensive network of federal contract awards with the Defense Logistics Agency. BENLYSTA, a specialized biologic medication, reflects the company's role in delivering specialty pharmaceuticals and medical supplies that support the medical needs of the Department of Defense and other federal healthcare systems. As a child contract under the SPE2DX indefinite delivery vehicle, this order demonstrates AmerisourceBergen's continued capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/18/25 |